Cargando…
Complete response with sorafenib and transcatheter arterial chemoembolization in unresectable hepatocellular carcinoma
Patients with advanced hepatocellular carcinoma (HCC) showing portal vein tumor thrombosis (PVTT) have an extremely poor prognosis. According to treatment guidelines, the only option for HCC patients with PVTT is sorafenib chemotherapy. However, in Asia, various treatments have been attempted and po...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Baishideng Publishing Group Inc
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5107709/ https://www.ncbi.nlm.nih.gov/pubmed/27895433 http://dx.doi.org/10.3748/wjg.v22.i42.9445 |